Roberto Cuca - Nov 29, 2021 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
COO and CFO
Signature
/s/ Roberto Cuca
Stock symbol
TELA
Transactions as of
Nov 29, 2021
Transactions value $
$38,245
Form type
4
Date filed
12/1/2021, 07:25 PM
Previous filing
Sep 29, 2021
Next filing
Dec 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Purchase $5.33K +423 $12.60 423 Nov 29, 2021 Direct F1
transaction TELA Common Stock Purchase $10.4K +838 +198.11% $12.43 1.26K Nov 30, 2021 Direct F2
transaction TELA Common Stock Purchase $22.5K +1.78K +141.16% $12.64 3.04K Dec 1, 2021 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.41 to $12.74. The Reporting Person undertakes to provide TELA Bio, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.40 to $12.49. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.55 to $12.65. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.